Publicacións nas que colabora con Jesús J. Sola (11)

2012

  1. Fc gamma receptor polymorphisms as predictive markers of Cetuximab efficacy in epidermal growth factor receptor downstream-mutated metastatic colorectal cancer

    European Journal of Cancer, Vol. 48, Núm. 12, pp. 1774-1780

  2. Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: A validation phase II trial

    International Journal of Radiation Oncology Biology Physics, Vol. 83, Núm. 2, pp. 587-593

2011

  1. MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells

    Stem Cells, Vol. 29, Núm. 11, pp. 1661-1671

  2. Patterns of response after preoperative treatment in gastric cancer

    International Journal of Radiation Oncology Biology Physics, Vol. 80, Núm. 3, pp. 698-704

2010

  1. A new mutation in the hMSH2 gene in a Spanish Lynch syndrome family

    Clinical and Translational Oncology, Vol. 12, Núm. 12, pp. 849-851

2009

  1. Factores ligados a angiogénesis, coagulación y fibrinólisis en el pronóstico de pacientes con cáncer colorectal

    Salud(i)Ciencia, Vol. 16, Núm. 8, pp. 848-854

  2. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells

    Clinical Cancer Research, Vol. 15, Núm. 7, pp. 2281-2290

2008

  1. Phase I-II Trial of Concurrent Capecitabine and Oxaliplatin With Preoperative Intensity-Modulated Radiotherapy in Patients With Locally Advanced Rectal Cancer

    International Journal of Radiation Oncology Biology Physics, Vol. 71, Núm. 3, pp. 748-755

2007

  1. A gene signature of 8 genes could identify the risk of recurrence and progression in Dukes' B colon cancer patients

    Oncology Reports, Vol. 17, Núm. 5, pp. 1089-1094

2004

  1. Dysregulation of apoptosis is a major mechanism in the lymph node involvement in colorectal carcinoma

    Oncology Reports, Vol. 12, Núm. 2, pp. 287-292

2003

  1. A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis

    Gastroenterology, Vol. 124, Núm. 4, pp. 1037-1042